A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma
Clinical trial NCT00111007 · COMPLETED
Trial details
- NCT number
- NCT00111007
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Primary completion
- 2006-09-01
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.